MaxCyte to Report Third Quarter 2025 Financial Results on November 5, 2025
MaxCyte (NASDAQ: MXCT) will report third quarter 2025 financial results after the U.S. market close on Wednesday, November 5, 2025.
Company management will host an earnings conference call at 4:30 p.m. Eastern Time the same day. Investors must register online in advance to join the call, and a live and archived webcast will be available in the Events section of MaxCyte's investor website at https://investors.maxcyte.com/.
MaxCyte (NASDAQ: MXCT) riferirà i risultati finanziari del terzo trimestre 2025 dopo la chiusura dei mercati statunitensi su mercoledì 5 novembre 2025.
La direzione della società terrà una conference call sugli utili alle ore 16:30, ora orientale nello stesso giorno. Gli investitori devono registrarsi online in anticipo per partecipare alla chiamata, e una trasmissione web in diretta e registrata sarà disponibile nella sezione Eventi del sito per gli investitori di MaxCyte all’indirizzo https://investors.maxcyte.com/.
MaxCyte (NASDAQ: MXCT) reportará los resultados financieros del tercer trimestre de 2025 después del cierre del mercado en miércoles, 5 de noviembre de 2025.
La dirección de la empresa organizará una llamada de conferencia sobre ganancias a las 4:30 p.m. hora del Este ese mismo día. Los inversores deben registrarse en línea con antelación para unirse a la llamada, y una transmisión web en vivo y archivada estará disponible en la sección Eventos del sitio para inversores de MaxCyte en https://investors.maxcyte.com/.
MaxCyte (NASDAQ: MXCT)는 2025년 3분기 실적을 미국 주식시장의 장 마감 이후 2025년 11월 5일 수요일에 발표합니다.
같은 날 오후 동부 표준시 4시 30분에 경영진이 실적 컨퍼런스 콜을 주최합니다. 참가하려면 사전에 온라인으로 등록해야 하며, 라이브 및 보관용 웹캐스트는 MaxCyte의 투자자 웹사이트의 이벤트 섹션에서 https://investors.maxcyte.com/에서 이용 가능합니다.
MaxCyte (NASDAQ: MXCT) publiera les résultats financiers du troisième trimestre 2025 après la clôture du marché américain le mercredi 5 novembre 2025.
La direction de l'entreprise animera une conférence téléphonique sur les résultats à 16 h 30, heure de l'Est le même jour. Les investisseurs doivent s'inscrire en ligne à l'avance pour participer à l'appel, et une webdiffusion en direct et archivée sera disponible dans la rubrique Événements du site pour les investisseurs de MaxCyte à l'adresse https://investors.maxcyte.com/.
MaxCyte (NASDAQ: MXCT) wird die Finanzergebnisse des dritten Quartals 2025 nach Börsenschluss in den USA am Mittwoch, dem 5. November 2025 bekanntgeben.
Die Geschäftsführung des Unternehmens wird am selben Tag eine Ergebniswebkonferenz um 16:30 Uhr Eastern Time ausrichten. Investoren müssen sich im Voraus online registrieren, um an der Call-Teilnahme teilzunehmen, und ein Live- sowie Archiv-Webcast wird im Bereich Veranstaltungen der Investorenseite von MaxCyte unter https://investors.maxcyte.com/ verfügbar sein.
MaxCyte (NASDAQ: MXCT) سيعلن عن نتائج الربع الثالث من 2025 بعد إغلاق السوق الأميركية يوم الأربعاء 5 نوفمبر 2025.
ستعقد إدارة الشركة مكالمة مؤتمر الأرباح في الساعة 4:30 مساءً بتوقيت الشرق في نفس اليوم. يجب على المستثمرين التسجيل عبر الإنترنت مسبقًا للانضمام إلى المكالمة، وستكون هناك بث مباشر واذاعة مسجلة متاحة في قسم الأحداث ضمن موقع MaxCyte الإلكتروني للمستثمرين على https://investors.maxcyte.com/.
MaxCyte (NASDAQ: MXCT) 将在美国市场收盘后于2025年11月5日，星期三公布2025年第三季度财务业绩。
同一天，公司管理层将主持一次东部时间下午4:30的收益电话会议。投资者须提前在线注册以参加电话会议，且现场及存档的网络广播将可在MaxCyte投资者网站的事件板块 https://investors.maxcyte.com/ 查看。
- None.
- None.
ROCKVILLE, Md., Oct. 08, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that it will release financial results for the third quarter 2025 after the U.S. market close on Wednesday, November 5th, 2025. Company management will host a conference call to discuss financial results at 4:30 p.m. Eastern Time.
Earnings Conference Call Details
Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the “Events” section of the MaxCyte website at https://investors.maxcyte.com/.
About MaxCyte
At MaxCyte®, we are committed to building better cells together. As a leading cell-engineering company, we are driving the discovery, development and commercialization of next-generation cell therapies. Our best-in-class Flow Electroporation® technology and SeQure DX™ gene editing risk assessment services enable precise, efficient and scalable cell engineering. Supported by expert scientific, technical and regulatory guidance, our platform empowers researchers from around the world to engineer diverse cell types and payloads, accelerating the development of safe and effective treatments for human health. For more than 25 years, we've been advancing cell engineering, shaping the future of medicine. Learn more at maxcyte.com and follow us on X and LinkedIn.
Investor Relations
Gilmartin Group
David Deuchler, CFA
+1 415-937-5400
ir@maxcyte.com
Media Relations
Oak Street Communications
Kristen White
+1 415-608-6060
kristen@oakstreetcommunications.com
FAQ
When will MaxCyte (MXCT) report Q3 2025 results?
What time is the MaxCyte (MXCT) Q3 2025 earnings call?
How can investors join the MaxCyte (MXCT) Q3 2025 earnings call?
Where can I find the live webcast for MaxCyte (MXCT) Q3 2025 results?
Will the MaxCyte (MXCT) Q3 2025 webcast be available after the call?
Do I need to register to access the archived MaxCyte (MXCT) earnings webcast?
